Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janneke G Langendonk

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Expert Review of Clinical Pharmacology|January 28, 2021
Afamelanotide for prevention of phototoxicity in erythropoietic protoporphyriaDebby Wensink, Margreet A E M Wagenmakers, Janneke G Langendonk
Seminars in Vascular Medicine|January 5, 2005
Molecular analysis of cardiovascular disease: some delay due to gene-environment interactionsEric J G Sijbrands, Geesje Dallinga-Thie, Janneke G Langendonk
World Journal of Gastroenterology|August 23, 2019
Letter to the editor: Diagnosis of erythropoietic protoporphyria with severe liver injury - a case reportDebby Wensink, Margreet Aem Wagenmakers, Jh Paul Wilson, et al.
JIMD Reports|February 23, 2013
Recommendations for pregnancies in patients with crigler-najjar syndromeJ H Paul Wilson, Maarten Sinaasappel, Fred K Lotgering, et al.
European Journal of Internal Medicine|November 14, 2006
Decrease in visceral fat following diet-induced weight loss in upper body compared to lower body obese premenopausal womenJanneke G Langendonk, Petra Kok, Marijke Frölich, et al.
The Journal of Dermatology|December 29, 2022
Erythropoietic protoporphyria in the Netherlands: Clinical features, psychosocial impact and the effect of afamelanotideDebby Wensink, Margreet A E M Wagenmakers, J H Paul Wilson, et al.
Orphanet Journal of Rare Diseases|April 27, 2020
Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reportsLena H P Vroegindeweij, Agnita J W Boon, J H Paul Wilson, et al.
JIMD Reports|November 7, 2022
Primary carnitine deficiency is a life-long diseaseLoek L Crefcoeur, Mireille C Melles, Tobias A Bruning, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2024
The Impact of Minimal Sunlight Exposure on Bone Health: Insights From a Cohort Study in Erythropoietic ProtoporphyriaLouisa G Kluijver, Margreet A E M Wagenmakers, J H Paul Wilson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2024
Erythropoietic protoporphyrias: Pathogenesis, diagnosis and managementAnna-Elisabeth Minder, Louisa G Kluijver, Jasmin Barman-Aksözen, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Expert Review of Clinical Pharmacology|January 28, 2021
Afamelanotide for prevention of phototoxicity in erythropoietic protoporphyriaDebby Wensink, Margreet A E M Wagenmakers, Janneke G Langendonk
Seminars in Vascular Medicine|January 5, 2005
Molecular analysis of cardiovascular disease: some delay due to gene-environment interactionsEric J G Sijbrands, Geesje Dallinga-Thie, Janneke G Langendonk
World Journal of Gastroenterology|August 23, 2019
Letter to the editor: Diagnosis of erythropoietic protoporphyria with severe liver injury - a case reportDebby Wensink, Margreet Aem Wagenmakers, Jh Paul Wilson, et al.
JIMD Reports|February 23, 2013
Recommendations for pregnancies in patients with crigler-najjar syndromeJ H Paul Wilson, Maarten Sinaasappel, Fred K Lotgering, et al.
European Journal of Internal Medicine|November 14, 2006
Decrease in visceral fat following diet-induced weight loss in upper body compared to lower body obese premenopausal womenJanneke G Langendonk, Petra Kok, Marijke Frölich, et al.
The Journal of Dermatology|December 29, 2022
Erythropoietic protoporphyria in the Netherlands: Clinical features, psychosocial impact and the effect of afamelanotideDebby Wensink, Margreet A E M Wagenmakers, J H Paul Wilson, et al.
Orphanet Journal of Rare Diseases|April 27, 2020
Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reportsLena H P Vroegindeweij, Agnita J W Boon, J H Paul Wilson, et al.
JIMD Reports|November 7, 2022
Primary carnitine deficiency is a life-long diseaseLoek L Crefcoeur, Mireille C Melles, Tobias A Bruning, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2024
The Impact of Minimal Sunlight Exposure on Bone Health: Insights From a Cohort Study in Erythropoietic ProtoporphyriaLouisa G Kluijver, Margreet A E M Wagenmakers, J H Paul Wilson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2024
Erythropoietic protoporphyrias: Pathogenesis, diagnosis and managementAnna-Elisabeth Minder, Louisa G Kluijver, Jasmin Barman-Aksözen, et al.
Pageof 8